HAEMATO AG INH O.N.HAEMATO AG INH O.N.HAEMATO AG INH O.N.

HAEMATO AG INH O.N.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪56.79 M‬EUR
‪1.65 M‬
Beta (1Y)
−0.92

About HAEMATO AG INH O.N.


CEO
Patrick Brenske
Website
Headquarters
Schönefeld
Founded
1993
ISIN
DE000A289VV1
FIGI
BBG000M8P7R5
Haemato AG engages in the pharmaceutical industry. It focuses on growth markets of patent-free, and patented medicinal products in the insurance-financed market. Its portfolio include therapies for cancer, HIV, rheumatology, and other chronic diseases, and products for the privately financed market for aesthetic treatments. It operates through the Lifestyle and Aesthetics, and Specially Pharma segments. The company was founded on May 10, 1993 and is headquartered in Schönefeld, Germany.

Check out other big names from the same industry as HAEK.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HAEK is 10.900 EUR — it hasn't changed in the past 24 hours. Watch HAEMATO AG INH O.N. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HAM exchange HAEMATO AG INH O.N. stocks are traded under the ticker HAEK.
HAEK stock has fallen by −2.68% compared to the previous week, the month change is a 3.81% rise, over the last year HAEMATO AG INH O.N. has showed a −33.94% decrease.
HAEK reached its all-time high on Apr 14, 2021 with the price of 35.500 EUR, and its all-time low was 10.000 EUR and was reached on Apr 1, 2025. View more price dynamics on HAEK chart.
See other stocks reaching their highest and lowest prices.
HAEK stock is 0.00% volatile and has beta coefficient of −0.92. Track HAEMATO AG INH O.N. stock price on the chart and check out the list of the most volatile stocks — is HAEMATO AG INH O.N. there?
Today HAEMATO AG INH O.N. has the market capitalization of ‪56.79 M‬, it has decreased by −0.88% over the last week.
Yes, you can track HAEMATO AG INH O.N. financials in yearly and quarterly reports right on TradingView.
HAEMATO AG INH O.N. is going to release the next earnings report on Aug 28, 2025. Keep track of upcoming events with our Earnings Calendar.
Yes, HAEK dividends are paid annually. The last dividend per share was 0.04 EUR. As of today, Dividend Yield (TTM)% is 0.37%. Tracking HAEMATO AG INH O.N. dividends might help you take more informed decisions.
Like other stocks, HAEK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HAEMATO AG INH O.N. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HAEMATO AG INH O.N. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HAEMATO AG INH O.N. stock shows the sell signal. See more of HAEMATO AG INH O.N. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.